Header cover image

South Korean (KOSPI) Pharma Industry Analysis

UpdatedSep 27, 2025
DataAggregated Company Financials
Companies105
  • 7D-3.9%
  • 3M15.1%
  • 1Y2.0%
  • YTD10.8%

Last week, the Pharma industry hasn't moved much but Hanmi Pharm is up 4.6% in that time. Furthermore, the industry has been flat for the past year as well. As for the next few years, earnings are expected to grow by 34% per annum.

Industry Valuation and Performance

Has the South Korean Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 27 Sep 2025₩61.9t₩31.1t₩925.9b20.4x66.9x2x
Mon, 25 Aug 2025₩57.7t₩31.0t₩894.3b20.5x64.6x1.9x
Wed, 23 Jul 2025₩59.5t₩30.4t₩918.0b17.7x64.9x2x
Fri, 20 Jun 2025₩53.6t₩30.1t₩903.8b16x59.3x1.8x
Sun, 18 May 2025₩52.6t₩29.6t₩969.5b17.5x54.2x1.8x
Tue, 15 Apr 2025₩52.6t₩29.5t₩971.7b17.5x54.1x1.8x
Thu, 13 Mar 2025₩54.4t₩29.5t₩1.0t12.7x54.2x1.8x
Sat, 08 Feb 2025₩58.7t₩29.6t₩1.0t11.9x57.5x2x
Mon, 06 Jan 2025₩55.4t₩29.7t₩994.8b12.5x55.7x1.9x
Wed, 04 Dec 2024₩52.9t₩29.4t₩988.8b11.9x53.5x1.8x
Fri, 01 Nov 2024₩59.5t₩28.7t₩833.2b15.3x71.4x2.1x
Sun, 29 Sep 2024₩59.0t₩28.8t₩836.8b15.3x70.5x2.1x
Tue, 27 Aug 2024₩57.7t₩28.7t₩852.9b15.3x67.6x2x
Thu, 25 Jul 2024₩56.2t₩28.4t₩762.2b15x73.7x2x
Sat, 22 Jun 2024₩52.7t₩30.2t₩909.5b13.5x57.9x1.7x
Mon, 20 May 2024₩54.9t₩29.7t₩936.7b18.1x58.6x1.8x
Wed, 17 Apr 2024₩50.4t₩29.4t₩922.9b16.4x54.6x1.7x
Fri, 15 Mar 2024₩54.3t₩29.6t₩787.7b20.1x68.9x1.8x
Sun, 11 Feb 2024₩50.8t₩29.6t₩593.1b21.3x85.6x1.7x
Tue, 09 Jan 2024₩53.9t₩29.6t₩588.5b23.3x91.6x1.8x
Thu, 07 Dec 2023₩49.5t₩29.6t₩590.4b21.7x83.9x1.7x
Sat, 04 Nov 2023₩46.5t₩29.3t₩683.3b15.8x68.1x1.6x
Mon, 02 Oct 2023₩50.9t₩29.3t₩683.3b17.1x74.5x1.7x
Wed, 30 Aug 2023₩50.9t₩29.3t₩735.6b20.6x69.2x1.7x
Fri, 28 Jul 2023₩48.8t₩28.8t₩899.2b21.3x54.3x1.7x
Sun, 25 Jun 2023₩47.5t₩28.9t₩908.3b20.8x52.3x1.6x
Tue, 23 May 2023₩48.2t₩28.7t₩827.0b21.1x58.3x1.7x
Thu, 20 Apr 2023₩49.4t₩28.5t₩602.7b20.1x81.9x1.7x
Sat, 18 Mar 2023₩44.8t₩27.7t₩595.6b20.8x75.2x1.6x
Mon, 13 Feb 2023₩45.7t₩27.7t₩743.5b19.8x61.4x1.6x
Wed, 11 Jan 2023₩45.2t₩28.0t₩770.2b19.7x58.6x1.6x
Fri, 09 Dec 2022₩45.2t₩28.0t₩770.0b19.1x58.8x1.6x
Sun, 06 Nov 2022₩42.3t₩27.2t₩694.8b20.6x60.8x1.6x
Tue, 04 Oct 2022₩41.6t₩27.2t₩694.8b18.8x59.8x1.5x
Price to Earnings Ratio

59.8x


Total Market Cap: ₩41.6tTotal Earnings: ₩694.8bTotal Revenue: ₩27.2tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Pharma Industry Price to Earnings3Y Average 65.1x202320242025
Current Industry PE
  • Investors are optimistic on the South Korean Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 68.3x which is higher than its 3-year average PE of 65.1x.
  • The 3-year average PS ratio of 1.8x is lower than the industry's current PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 10% per year over the last three years.
  • Revenues for these companies have grown 4.5% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare industry?

KR Market-1.80%
Healthcare-2.69%
Pharma-3.90%
Pharma-3.90%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A128940 Hanmi Pharm₩377.00k4.6%
+₩209.2b
20.3%PE44.5x
A140410 Mezzion PharmaLtd₩66.30k11.2%
+₩201.8b
130.2%PS253.3x
A309710 IT-ChemLtd₩29.70k20.2%
+₩62.9b
n/aPE315.2x
A067080 DAE HWA Pharmaceutical₩17.23k19.7%
+₩49.6b
32.7%PE462.7x
A039200 Oscotec₩44.50k2.5%
+₩42.1b
35.5%PE400.2x

Latest News